The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

"The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox, ...

Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops ...

Toxoplasmosis and MDD were among several preexisting comorbidities associated with the development of neurocognitive disorders in patients with HIV infection.

Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...

In 1985, the first year that a test for HIV became available, Mike Hellman tested positive. It was a terrifying diagnosis at ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Bridgette J. Picou, LVN, ACLPN, presented research on the lived experiences of women living with HIV and going through ...